Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: Findings from the National Health and Nutrition Examination Survey, 1999-2008

Diabetes Care

Volumn 34, Issue 6, 2011, Pages 1337-1343

  Ford, Earl S ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE SURVEILLANCE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREND STUDY;

ADULT; AFRICAN AMERICANS; AGED; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; SMOKING; UNITED STATES;

EID: 80051962202     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2251     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, United States, 1965-2007 [article online], 2010. Available at http://www.cdc.gov/tobacco/data-statistics/tables/ trends/cig-smoking/index.htm. Accessed 18 April 2011
2. Carroll M.D., Lacher D.A., Sorlie P.D., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-1781 (Pubitemid 41434623)
3. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-2050
4. Hoerger T.J., Zhang P., Segel J.E., Gregg E.W., Narayan K.M., Hicks K.A. Improvements in risk factor control among persons with diabetes in the United States: Evidence and implications for remaining life expectancy. Diabetes Res Clin Pract 2009;86:225-232
5. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey [article online], 2010. Available at http://www.cdc.gov/ nchs/nhanes.htm. Accessed 18 April 2011
6. Stevens R.J., Kothari V., Adler A.I., Stratton I.M.; United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-679 (Pubitemid 33135349)
7. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847 (Pubitemid 28213628)
8. Folsom A.R., Chambless L.E., Duncan B.B., Gilbert A.C., Pankow J.S.; Atherosclerosis Risk in Communities Study Investigators. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 2003;26:2777-2784 (Pubitemid 37205546)
9. National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2007 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD, U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2007
10. Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398 (Pubitemid 46883773)
11. Fox C.S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499 (Pubitemid 39552675)
12. Gregg E.W., Gu Q., Cheng Y.J., Narayan K.M., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007;147:149-155 (Pubitemid 351664594)
13. Preis S.R., Hwang S.J., Coady S., et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119:1728-1735
14. Ford E.S., Li C., Pearson W.S., Zhao G., Mokdad A.H. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol 2010;140:226-235
15. Skyler J.S., Bergenstal R., Bonow R.O., et al.; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: Implications of the ACCORD, ADVANCE, and VA diabetes trialsA position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-192
16. Vijan S., Hayward R.A. Treatment of hypertension in type 2 diabetes mellitus: Blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138:593-602
17. Kearney P.M., Blackwell L., Collins R., et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 2008;371:117-125
18. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393 (Pubitemid 36159355)
19. Coleman R.L., Stevens R.J., Retnakaran R., Holman R.R. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007;30:1292-1293
20. Guzder R.N., Gatling W., Mullee M.A., Mehta R.L., Byrne C.D. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: Results from a United Kingdom study. Diabet Med 2005;22:554-562 (Pubitemid 40593130)
21. Davis W.A., Colagiuri S., Davis T.M. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust 2009;190:180-184
22. Simmons R.K., Coleman R.L., Price H.C., et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort. Diabetes Care 2009;32:708-713
23. Van der Heijden A.A., Ortegon M.M., Niessen L.W., Nijpels G., Dekker J.M. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: Accuracy of the Framingham, SCORE, and UKPDS risk functions: Accuracy of the Framingham, SCORE, and UKPDS risk functionsThe Hoorn Study. Diabetes Care 2009;32:2094-2098
24. Kengne A.P., Patel A., Colagiuri S., et al.; ADVANCE Collaborative Group. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: The Action in Diabetes and Vascular Disease: The Action in Diabetes and Vascular DiseasePreterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010;53:821-831
25. Metcalf P.A., Wells S., Scragg R.K., Jackson R. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with type 2 diabetes mellitus. N Z Med J 2008;121:49-57